Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	1L 1L 1L 1L 2L 1.42Cr 2L 14.12L 5L 71.54L 6L 5L 2.37Cr	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	1.32Cr 1.54Cr 1.24Cr 1.13Cr 2.14Cr 147.92Cr 2.16Cr 15Cr 5.7Cr 74Cr 5.8Cr 5.67Cr 245.76Cr	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

30/06	Safe Group sharply improves its full-year results
29/06	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
28/05	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
28/05	Safe Group enters Peru with exclusive distribution agreement
16/03	Changes to the SAFE Board of Directors
17/12	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
17/12	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
01/12	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Alert wrongly tagged to Safe SA withdrawn	RE
27/24/27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/24/09	The market burns its idols
05/24/05	Safe: wins its appeal against Neo Medical
28/23/28	Safe: audit initiated for a turnaround plan

22/12	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/24/09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/23/24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

30/06	Safe Group améliore nettement ses résultats annuels
28/05	Safe Group s'implante au Pérou avec un accord de distribution exclusif
28/04	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
31/03	SAFE - Forte dynamique de développement au Venezuela
16/03	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Share Price Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	1L
STRYKER CORPORATION	-0.50%	-1.17%	-16.85%	+19.88%	13TCr
SMITH & NEPHEW PLC	+1.17%	-0.55%	-21.76%	+1.98%	1.24TCr
GLAUKOS CORPORATION	+0.41%	+0.02%	+97.19%	+152.93%	1.09TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.04%	-8.13%	-52.54%	-69.79%	409.79Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+2.94%	+3.55%	-22.09%	+54.01%	276.71Cr
INSPIRE MEDICAL SYSTEMS, INC.	-1.43%	+7.43%	-35.96%	-71.44%	177.71Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.25%	-2.62%	-25.37%	-14.55%	162.45Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-3.08%	-5.02%	-37.51%	-38.93%	155.88Cr
Average	-0.51%	-0.38%	-14.36%	+4.26%	2.01TCr
Weighted average by Cap.	-0.32%	-1.03%	-10.97%	+23.93%

	2024	2025
Net sales	50.41L 58.82L 47.16L 43.11L 81.36L 56Cr 82.23L 5.58Cr 2.17Cr 28Cr 2.21Cr 2.16Cr 94Cr	53.64L 62.59L 50.18L 45.88L 86.57L 60Cr 87.5L 5.94Cr 2.31Cr 30Cr 2.35Cr 2.3Cr 100Cr
Net income	-192.93Cr -225.13Cr -180.49Cr -165.01Cr -311.39Cr -22TCr -314.7Cr -2.14TCr -830.46Cr -11TCr -845.28Cr -826.97Cr -36TCr	-46.74L -54.54L -43.73L -39.98L -75.44L -52Cr -76.24L -5.17Cr -2.01Cr -26Cr -2.05Cr -2Cr -87Cr
Net Debt	1.15Cr 1.34Cr 1.07Cr 98.11L 1.85Cr 128.17Cr 1.87Cr 13Cr 4.94Cr 64Cr 5.03Cr 4.92Cr 212.93Cr	1.31Cr 1.53Cr 1.23Cr 1.12Cr 2.12Cr 146.5Cr 2.14Cr 15Cr 5.64Cr 74Cr 5.74Cr 5.62Cr 243.4Cr